Eli Lilly (LLY) Interest Expenses (2009 - 2012)

Eli Lilly (LLY) has reported Interest Expenses for 4 consecutive years, with $45.3 million the latest figure, recorded in Q1 2012.

• Interest Expenses for Q1 2012 came in at $45.3 million, down 1.09% year-over-year; the trailing twelve-month figure through Dec 2012 was $45.3 million (down 75.65% YoY), and the FY2011 annual result was $186.0 million, changed 0.27% from the prior year.
• Interest Expenses was $45.3 million for Q1 2012 at Eli Lilly, down from $50.1 million in the prior quarter.
• Over five years, Interest Expenses peaked at $64.3 million in Q2 2009 and troughed at $43.2 million in Q4 2010.
• Average Interest Expenses over 4 years is $48.1 million, with a median of $46.5 million recorded in 2010.
• Year-over-year, Interest Expenses dropped 26.13% in 2010 and advanced 15.97% in 2011.
• Over 4 years, Interest Expenses stood at $64.3 million in 2009, then tumbled by 32.81% to $43.2 million in 2010, then grew by 15.97% to $50.1 million in 2011, then fell by 9.58% to $45.3 million in 2012.
• Per Business Quant data, the three most recent Interest Expenses figures were $45.3 million in Q1 2012, $50.1 million in Q4 2011, and $45.0 million in Q3 2011.